Dendritic cells: Sentinels against pathogens

Histology and Histopathology

Volumn 19, Issue 1, 2004, Pages 317-324

  Chung, N P Y ^a   Chen, Y ^a   Chan, Vera S F ^a   Tam, P K H ^a   Lin, C L S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer immunotherapy; Chemokine; Dendritic cells; Immunity; Maturation

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE ACTIVATION; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL MIGRATION; CHEMOTAXIS; DENDRITIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOBIOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; LYMPHOID ORGAN; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ANIMALS; ANTIGEN PRESENTATION; CELL DIVISION; CELL MOVEMENT; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MODELS, BIOLOGICAL; NEOPLASMS; T-LYMPHOCYTES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 1642515006     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Allavena P., Piemonti L., Longoni D., Bernasconi S., Stoppacciaro A., Ruco L. and Mantovani A. (1998) IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28, 359-369
2. Banchereau J. and Steinman R. (1998). Dendritic cells and control of immunity. Nature 392, 245-252.
3. Bender A., Sapp M., Schuler G., Steinman R. and Bhardwaj N. (1996). Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196, 121-135.
4. Brocker T., Riedinger M. and Karjalainen K. (1997). Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185, 541-550.
5. Cambi A., Gijzen K., De Vries J.M., Torensma R., Joosten B., Adema G., Netea M., Kullberg B., Romani L. and Figdor C. (2003). The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 33,532-528.
6. Caux C., Dezutter-Dambuyant C., Schmitt D. and Banchereau J. (1992). GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360, 258-261.
7. Caux C., Vanbervliet B., Massacrier C., Azuma M., Okumura K., Lanier L. and Banchereau J. (1994). B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180, 1841-1847.
8. Cella M., Sallusto F. and Lanzavecchia A. (1997). Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10-16.
9. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I. and Lanzavecchia A. (1999). Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189, 821-829.
10. Cosman D., Fanger N. and Borges L. (1999). Human cytomegalovirus, MHC class I and inhibitory signalling receptors: More questions than answers. Immunol. Rev. 168, 177-185.
11. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Patterson L. and Hsu M. (1997). A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7, 273-282.
12. Colmenares M., Puig-Kroger A., Pello O., Corbi A. and Rivas L. (2002). Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing non-integrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem. 277, 36766-36799.
13. Dhodapkar M., Steinman R., Krasovsky J., Munz C. and Bhardwaj N. (2001). Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238.
14. DeMatos P., Abdel-Wahab Z., Vervaert C. and Seigler H. (1998). Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice. Cell. Immunol. 185, 65-74.
15. Enk A., Saloga J., Becker D., Mohamadzadeh M. and Knop J. (1994). Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179, 1397-1402.
16. Enk A., Jonuleit H., Saloga J. and Knop J. (1997). Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer 73, 309-316.
17. Fe'd'Ostiani C., Del Sero G., Bacci A., Montagnoli C., Ricciardi-Castagnoli P., Spreca A. and Romani L. (2000). Dendritic cells discriminate between yeast and hyphae of the fungus Candida albicans: Implications for initiation of Th immunity in vitro and in vivo. J. Exp. Med. 191, 1661-1674.
18. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan M., Liu Y. and Rabourdin-Combe C. (1997). Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186, 813-823.
19. Gabrilovich D., Chen H., Girgis K., Cunningham H., Meny G., Nadaf S., Kavanaugh D. and Carbone D. (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2, 1096-1103.
20. Geijtenbeek T., Torensma R., Van Vliet S., Van Duijnhoven G., Adema G., Van Kooyk Y. and Figdor C. (2000a). Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585.
21. Geijtenbeek T., Kwon D., Torensma R., Van Vliet S., Van Duijnhoven G., Middel J., Cornelissen I., Nottet H., KewalRamani V., Littman D., Figdor C. and Van Kooyk Y. (2000b). DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587-597.
22. Grouard G., Rissoan M., Filgueira L., Durand I., Banchereau J. and Liu Y. (1997). The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185, 1101-1111.
23. + T cells. J. Exp. Med. 186, 801-812.
24. Gong J., Chen D., Kashiwaba M., Li Y., Chen L., Takeuchi H., Qu H., Rowse G., Gendler S. and Kufe D. (1998). Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc. Natl. Acad. Sci. USA 95, 6279-6283.
25. Granilli-Piperno A., Pope M., Inaba K. and Steinman R. (1995). Coexpression of NF-κB/Rel and SpI transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia. Proc. Natl. Acad. Sci. USA. 92, 10944-10948.
26. Halary F., Amara A., Lortat-Jacob H., Messerle M., Delaunay T., Houles C., Fieschi F., Arenzana-Seisdedos F., Moreau J. and Dechanet-Merville J. (2002). Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17, 653-664.
27. Hahn G., Jorges R., and Mocarski E. (1998). Cytomegolavirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95, 3937-3942.
28. Ho L., Wang J., Shaio M., Kao C., Chang D., Han S. and Lai J. (2001). Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166, 1499-1506.
29. Hsu F., Benike C., Fagnoni F., Liles T., Czerwinski D., Taidi B., Engleman E. and Levy R. (1996). Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2, 52-58.
30. Inaba K., Turley S., Yamaide F., Iyoda T., Mahnke K., Inaba M., Pack M., Subklewe M., Sauter B., Sheff D., Albert M., Bhardwaj N., Mellman I. and Steinman R. (1998). Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163-2173.
31. Iwai H., Kuma S., Inaba M., Good R., Yamashita T., Kumazawa T. and Ikehara S. (1989). Acceptance of murine thyroid allografts by pretreatment of anti-la antibody or anti-dendritic cell antibody in vitro. Transplantation 47, 45-49.
32. Iwamoto M., Shinohara H., Miyamoto A., Okuzawa M., Mabuchi H., Nohara T., Gon G., Toyoda M. and Tanigawa N. (2003). Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int. J. Cancer 104, 92-97.
33. Libraty D., Pichyangkul S., Ajariyakhajorn C., Endy T. and Ennis F. (2001). Human dendritic cells are activated by dengue virus infection: Enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75, 3501-3508.
34. Lin C., Suri R., Rahdon R., Austyn J. and Roake J. (1998). Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur. J. Immunol. 12, 4114-4122.
35. Lin C., Sewell A., Gao G., Whelan K., Phillips R. and Austyn J. (2000). Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J. Exp. Med. 192, 587-594.
36. + T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. Cancer Res. 62, 6952-6958.
37. Lutz M., Suri R., Niimi M., Ogilvie A., Kukutsch N., Rossner S., Schuler G. and Austyn J. (2000). Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30, 1813-1822.
38. McWilliam A., Napoli S., Marsh A., Pemper F., Nelson D., Pimm C., Stumbles P., Wells T. and Holt P. (1996). Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184, 2429-2432.
39. Mackay C. (2001). Chemokines: Immunology's high impact factors. Nat. Immunol. 2, 95-101.
40. Mayordomo J., Zorina T., Storkus W., Zitvogel L., Celluzzi C., Falo L., Melief C., Ildstad S., Kast W., Deleo A. and Lotze M. (1995). Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat. Med. 1, 1297-1302.
41. Marovich M., McDowell M., Thomas E. and Nutman T. (2000). IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J. Immunol. 164, 5858-5865.
42. Moll H. (1993). Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Immunol. Today 14, 383-387.
43. Nestle F., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G. and Schadendorf D. (1998). Vaccination of melanoma patient with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4, 328-332.
44. Olweus J., BitMansour A., Warnke R., Thompson P., Carballido J., Picker L. and Lund-Johansen F. (1997). Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin. Proc. Natl. Acad. Sci. USA. 94, 12551-12556.
45. Ogata M., Zhang Y., Wang Y., Itakura M., Zhang Y., Harada A., Hashimoto S. and Matsushima K. (1999). Chemotactic response toward chemokines and its regulation by transforming growth factor-beta1 of murine bone marrow hematopoitic progenitor cell-derived different subset of dendritic cells. Blood 93, 3225-3232.
46. O'Doherty U., Peng M., Gezelter S., Swiggard W., Betjes M., Bhardwaj N. and Steinman R. (1994). Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82, 487-493.
47. Oyama T., Ran S., Ishida T., Nadaf S., Kerr L., Carbone D.P. and Gabrilovich D.I. (1998). Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J. Immunol. 160, 1224-1232.
48. Papadopoulos E., Sassetti C., Saeki H., Yamada N., Kawamura T., Fitzhugh D., Saraf M., Schall T., Blauvelt A., Rosen S. and Hwang T. (1999). Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur. J. Immunol. 29, 2551-2559.
49. Prebeck S., Kirschning C., Durr S., Da Costa C., Donath B., Brand K., Redecke V., Wagner H. and Miethke T. (2001). Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J. Immunol. 167, 3316-3323.
50. Randolph G., Beaulieu S., Lebecque S., Steinman R. and Muller W. (1998). Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480-483.
51. Reis e Sousa C., Hiney S., Scharton-Kersten T., Jankovic D., Charest H., Germain R. and Sher A. (1997). In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186, 1819-1829.
52. Riegler S., Hebart H., Einsele H., Brossart P., Jahn G. and Sinzer C. (2000). Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 81, 393-399.
53. Romani L., Bistoni F. and Puccetti P. (2002). Fungi, dendritic cells and receptors: A host perspective of fungal virulence. Trends Microbiol. 10, 508-514.
54. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trokenbacher B., Konwalinka G., Fritsch P., Steinman R. and Schuler G. (1994). Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93.
55. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D. and Schuler G. (1996). Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196, 137-151.
56. Roncarolo M., Levings M. and Traversari C. (2001). Differentiation of T regulatory cells by immature dendritics cells. J. Exp. Med. 193, F5-9.
57. Sewell A. and Price D. (2001). Dendritic cells and transmission of HIV-1. Trends Immunol. 22, 173-175.
58. Sallusto F. and Lanzavecchia A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
59. Sallusto F., Cella M., Danieli C. and Lanzavecchia A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400.
60. Schnorr J., Xanthakos S., Keikavoussi P., Kampgen E., Ter Meulen V. and Schneider-Schaulies S. (1997). Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. USA. 94, 5326-5331.
61. Spira A., Marx P., Patterson B., Mahoney J., Koup R., Wolinsky S., Ho D. (1996). Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183, 215-225.
62. +) T cells resulting in a failure to lyse tumor cells. Blood 93, 1634-1642.
63. Steinman R. and Cohn Z. (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142-1162.
64. Tassaneetrithep B., Burgess T., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M., Pattanapanyasat K., Sarasombath S., Birx D., Steinman R., Schlesinger S. and Marovich M. (2003). DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823-829.
65. Urban B., Ferguson D., Pain A., Willcox N., Plebanski M., Austyn J. and Roberts D. (1999). Plamodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400, 73-77.
66. Verdijk R., Mutis T., Esendam B., Kamp J., Melief C., Brand A. and Goulmy E. (1999). Polyriboinosinic polyribocytidylic acid (Poly(I:C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163, 57-61.
67. Wong B., Josien R., Lee S., Sauter B., Li H., Steinman R. and Choi Y. (1997). TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186, 2075-2080.
68. Winzler C., Rovere P., Rescigno M., Granucci F., Penna G., Adorini L., Zimmermann V., Davoust J. and Ricciardi-Castagnoli P. (1997). Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185, 317-328.
69. Wheatley G., McKinnon K., Iacobucci M., Mahon S., Gelber C. and Lyerly H. (1998). Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma. Surgery 124, 171-176.
70. Wu S., Grouard-Vogel G., Sun W., Mascola J., Brachtel E., Putvatana R., Louder M., Filgueira L., Marovich M., Wong H. Blauvelt A., Murphy G., Robb M., Innes B., Birx D., Hayes C. and Frankel S. (2000). Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6, 816-820.
71. Zhou L. and Tedder T. (1995). Human blood dendritic cells selectivity express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154, 3821-3835.